The share price of Chembio Diagnostics Inc. (NASDAQ:CEMI) rose to $0.73 per share on Tuesday from $0.63. While Chembio Diagnostics Inc. has overperformed by 15.37%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CEMI fell by -75.18%, with highs and lows ranging from $3.78 to $0.42, whereas the simple moving average fell by -34.56% in the last 200 days.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Sponsored
On July 22, 2021, Colliers Securities Downgraded Chembio Diagnostics Inc. (NASDAQ: CEMI) to Neutral. A report published by Craig Hallum on December 03, 2020, Upgraded its rating to ‘Buy’ for CEMI. Colliers Securities also Upgraded CEMI shares as ‘Buy’, setting a target price of $7.50 on the company’s shares in a report dated November 06, 2020. Craig Hallum June 17, 2020d its ‘Buy’ rating to ‘Hold’ for CEMI, as published in its report on June 17, 2020. Canaccord Genuity’s report from June 17, 2020 suggests a price prediction of $7 for CEMI shares, giving the stock a ‘Hold’ rating. Robert W. Baird also rated the stock as ‘Outperform’.
Analysis of Chembio Diagnostics Inc. (CEMI)
Further, the quarter-over-quarter increase in sales is 116.10%, showing a positive trend in the upcoming months.
To gain a thorough understanding of Chembio Diagnostics Inc.’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -123.40% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.70, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and CEMI is recording an average volume of 155.01K. On a monthly basis, the volatility of the stock is set at 8.88%, whereas on a weekly basis, it is put at 9.55%, with a gain of 10.31% over the past seven days.
How Do You Analyze Chembio Diagnostics Inc. Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.10%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 9.60% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in CEMI shares?
The recent increase in stakes in CEMI appears to be a result of several institutional investors and hedge funds increasing their positions. The Vanguard Group, Inc.’s position in CEMI has decreased by -21.58% in the first quarter. The company now owns 1,094,907 shares of the stock, with a value of $0.71 million, following the sale of -301,221 additional shares during the last quarter. BlackRock Fund Advisors made another increased to its shares in CEMI during the first quarter, upping its stake by 1.71%. During the last quarter, the company dropped down 4,661 additional shares for a total stake of worth $0.18 million, bringing number of shares owned by the company to 276,658.
During the first quarter, Geode Capital Management LLC subtracted a -4 position in CEMI. Susquehanna Investment Group LLC sold an additional 2261.0 shares in the last quarter, decreasing its holdings by -1.08%, now holding 0.21 million shares worth $0.13 million. At the end of the first quarter, Royce & Associates LP decreased its CEMI holdings by -56.80% and now holds 0.14 million CEMI shares valued at $88270.0 with the lessened -0.18 million shares during the period. CEMI shares are owned by institutional investors to the tune of 9.60% at present.
